Cancelled: Meet us at SCM20

27. Feb 2020 | 9 min read

Cancelled: Meet us at SCM20

Did you plan to visit our booth at SCM20? Send an email to marketing@gentian.com and one of our Product Manager will reach out to you. Remember SCM20 is streaming live so you can follow the conference from your office or home.

Contact Gentian

 

Gentian at NKF SCM20 – Booth #233 

We look forward to exhibiting at Spring Clinical Meetings 2020 and we hope to see you in New Orleans from March 26th to 28th to discuss cystatin Ckidney health and chronic kidney diseases (CKD). 

Chronic kidney disease care 

An important objective of SCM20 is to present the latest insights into chronic kidney disease care. Cystatin C is a superior prognostic and diagnostic marker for assessment of glomerular filtration rate (GFR). The marker is independent of protein intake, gender, ethnicity, age* and muscle mass [1-4]. 

 

Visit us at booth #233 

At booth #233 you will meet our Product Manager for cystatin C and our US Product Specialist. They will tell you more about our cystatin C immunoassay and cystatin C in the clinical settings, and can answer all your questions.

Book a meeting 

Book a meeting through marketing@gentian.com or fill out the form below: 

 

 

FDA510(k) cleared and CE-marked 

The Gentian Cystatin C Immunoassay is FDA510(k) cleared and CE-marked. The assay is also ERM-DA471 and IFCC standardised.  

 

PETIA 

The immunoassay is a Particle-Enhanced Turbidimetric Immunoassay (PETIA) for in vitro diagnostic testing of cystatin C in human plasma and serum samples. It can be performed in as little as 10 minutes with minimal hands-on time. 

The Gentian Cystatin C Immunoassay is used on a wide range of clinical chemistry analysers with documented high inter instrument accuracy [5]. 

 

Have you watched the webinar about kidney biomarkers by Professor Grubb yet? 

In the AACC webinar “The Use of Biomarkers in Chronic Kidney Disease and the Novel Disorder Shrunken Pore Syndrome (SPS) Dr. Grubb talks about cystatin C and SPS and discusses the use of biomarkers to estimate GFR showing the clinical value cystatin C can have in renal diagnostics. The webinar gives 1.0 ACCENT Credits.

The webinar is sponsored by Gentian.

Get in touch with our Product Manager for Cystatin C

 


References
 

  1. KDIGO Guidelines 2012 published in Kidney International Supplements Vol3 Issue 1, Jan 2013.  
  2. NCIC Clinical guideline (CG182) updated jan 2014 section 2.1 https://www.nice.org.uk/guidance/cg182/chapter/2-Implementation-getting-started 
  3. Tangri N, et al. Kidney Int 2011;79:471-7.  
  4. Grubb A, et al. eJIFCC 2017 Vol 28 NO4 pp 268-276. 
  5. Eckfeldt JH et al, Arch Pathol Lab Med 2015;139:888-93. 

 

*Not cleared for pediatric use in the USA

You may also read


What type of antibodies are used in Gentian’s Cystatin C Immunoassay?

May 20, 2020

What type of antibodies are used in Gentian’s Cystatin C Immunoassay?

In this segment we will answer questions our Product Manager for cystatin C and Product Specialist in the US..

Gentian Insight: PETIA

May 06, 2020

Gentian Insight: PETIA

Gentian’s proprietary antibody and nanoparticle-based technology supports development of highly sensitive..

Webinar: Why choose Gentian Cystatin C Immunoassay

Apr 30, 2020

Webinar: Why choose Gentian Cystatin C Immunoassay

Want to know more about Gentian’s cystatin C immunoassay? Watch this webinar with Gentian’s Product Manager..